Checkpoint Therapeutics Inc (CKPT) — Cash Flow-to-Debt Ratio
Latest as of March 2025:
-0.65x
Checkpoint Therapeutics Inc (CKPT) has a Cash Flow-to-Debt Ratio of -0.65x as of March 2025, meaning its operating cash flow of $-11.69 Million could theoretically repay -1% of its total liabilities ($17.87 Million) in one year. See financial agility of Checkpoint Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.65x
Operating CF / Total Liabilities
Operating Cash Flow
$-11.69 Million
USD
Total Liabilities
$17.87 Million
USD
Data as of
Mar 2025
Most recent filing
Checkpoint Therapeutics Inc Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Checkpoint Therapeutics Inc across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Checkpoint Therapeutics Inc.
Annual Cash Flow-to-Debt Ratio for Checkpoint Therapeutics Inc (2015–2024)
Year-by-year debt coverage analysis for Checkpoint Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.55x | $-31.10 Million | $20.10 Million | ▲ +40.1% |
| 2023 | -2.58x | $-47.59 Million | $18.43 Million | ▼ -47.1% |
| 2022 | -1.76x | $-57.55 Million | $32.77 Million | ▼ -73.5% |
| 2021 | -1.01x | $-26.31 Million | $25.98 Million | ▲ +55.9% |
| 2020 | -2.29x | $-16.55 Million | $7.22 Million | ▲ +12.9% |
| 2019 | -2.63x | $-21.37 Million | $8.12 Million | ▼ -33.6% |
| 2018 | -1.97x | $-25.80 Million | $13.09 Million | ▲ +18.8% |
| 2017 | -2.43x | $-15.46 Million | $6.37 Million | ▲ +10.4% |
| 2016 | -2.71x | $-9.95 Million | $3.67 Million | ▼ -941.0% |
| 2015 | -0.26x | $-1.11 Million | $4.26 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.